Show simple item record

dc.contributor.authorGidlow, C
dc.contributor.authorEllis, N.J.
dc.contributor.authorCowap, L
dc.contributor.authorRiley, V
dc.contributor.authorCrone, Diane
dc.contributor.authorCottrell, E
dc.contributor.authorGrogan, S
dc.contributor.authorChambers, R
dc.contributor.authorClark-Carter, D
dc.date.accessioned2019-01-31T10:49:57Z
dc.date.available2019-01-31T10:49:57Z
dc.date.issued2019-01-14
dc.identifier.citationGidlow, C.J., Ellis, N.J., Cowap, L., Riley, V., Crone, D., Cottrell, E., Grogan, S., Chambers, R. and Clark-Carter, D. (2019) 'A qualitative study of cardiovascular disease risk communication in NHS Health Check using different risk calculators: protocol for the RIsk COmmunication in NHS Health Check (RICO) study', BMC Family Practice, 20(1), p.11. https://doi.org/10.1186/s12875-018-0897-0en_US
dc.identifier.issn1471-2296
dc.identifier.urihttp://hdl.handle.net/10369/10254
dc.descriptionArticle published in BMC Family Practice, available open access at https://doi.org/10.1186/s12875-018-0897-0en_US
dc.description.abstractBackground NHS Health Check is a national cardiovascular disease (CVD) risk assessment programme for 40–74 year olds in England, in which practitioners should assess and communicate CVD risk, supported by appropriate risk-management advice and goal-setting. This requires effective communication, to equip patients with knowledge and intention to act. Currently, the QRISK®2 10-year CVD risk score is most common way in which CVD risk is estimated. Newer tools, such as JBS3, allow manipulation of risk factors and can demonstrate the impact of positive actions. However, the use, and relative value, of these tools within CVD risk communication is unknown. We will explore practitioner and patient CVD risk perceptions when using QRISK®2 or JBS3, the associated advice or treatment offered by the practitioner, and patients’ responses. Methods RIsk COmmunication in NHS Health Check (RICO) is a qualitative study with quantitative process evaluation. Twelve general practices in the West Midlands of England will be randomised to one of two groups: usual practice, in which practitioners use QRISK®2 to assess and communicate CVD risk; intervention, in which practitioners use JBS3. Twenty Health Checks per practice will be video-recorded (n = 240, 120 per group), with patients stratified by age, gender and ethnicity. Post-Health Check, video-stimulated recall (VSR) interviews will be conducted with 48 patients (n = 24 per group) and all practitioners (n = 12–18), using video excerpts to enhance participant recall/reflection. Patient medical record reviews will detect health-protective actions in the first 12-weeks following a Health Check (e.g., lifestyle referrals, statin prescription). Risk communication, patient response and intentions for health-protective behaviours in each group will be explored through thematic analysis of video-recorded Health Checks (using Protection Motivation Theory as a framework) and VSR interviews. Process evaluation will include between-group comparisons of quantitatively coded Health Check content and post-Health Check patient outcomes. Finally, 10 patients with the most positive intentions or behaviours will be selected for case study analysis (using all data sources). Discussion This study will produce novel insights about the utility of QRISK®2 and JBS3 to promote patient and practitioner understanding and perception of CVD risk and associated implications for patient intentions with respect to health-protective behaviours (and underlying mechanisms). Recommendations for practice will be developed.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofseriesBMC Family Practice;
dc.subjectCardiovascular disease, Risk communication, Health check, Chronic disease prevention, Protection motivation theoryen_US
dc.titleA qualitative study of cardiovascular disease risk communication in NHS Health Check using different risk calculators: protocol for the RIsk COmmunication in NHS Health Check (RICO) study. BMC family practice, 20(1), 11.en_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1186/s12875-018-0897-0
dcterms.dateAccepted2018-12-26
rioxxterms.funderNational Institute for Health Researchen_US
rioxxterms.funderCardiff Metropolitan Universityen_US
rioxxterms.identifier.projecthttps://doi.org/10.1186/ISRCTN10443908 Understanding the influence of NHS Health Check Cardiovascular Disease (CVD) Risk Assessment Toolsen_US
rioxxterms.identifier.projectCardiff Metropolian (Internal)en_US
rioxxterms.versionVoRen_US
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/en_US
rioxxterms.licenseref.startdate2019-01-31
rioxxterms.funder.project1d76dd6d-c564-4947-9a0d-d6f7c5983c73en_US
rioxxterms.funder.project37baf166-7129-4cd4-b6a1-507454d1372een_US


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record